142 related articles for article (PubMed ID: 34998604)
21. Dissolving polymer microneedle patches for influenza vaccination.
Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch.
Zhu W; Li S; Wang C; Yu G; Prausnitz MR; Wang BZ
Front Immunol; 2018; 9():1705. PubMed ID: 30105019
[TBL] [Abstract][Full Text] [Related]
23. Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells.
Hirobe S; Yamasaki T; Ito S; Quan YS; Kamiyama F; Tachibana M; Okada N
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214117
[TBL] [Abstract][Full Text] [Related]
24. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN.
Qiu Y; Guo L; Zhang S; Xu B; Gao Y; Hu Y; Hou J; Bai B; Shen H; Mao P
Drug Deliv; 2016 Sep; 23(7):2391-2398. PubMed ID: 25625495
[TBL] [Abstract][Full Text] [Related]
25. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.
Balmert SC; Carey CD; Falo GD; Sethi SK; Erdos G; Korkmaz E; Falo LD
J Control Release; 2020 Jan; 317():336-346. PubMed ID: 31756393
[TBL] [Abstract][Full Text] [Related]
26. Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.
Takatani-Nakase T; Tokuyama E; Komai M; Takahashi K
PLoS One; 2012; 7(10):e47980. PubMed ID: 23110149
[TBL] [Abstract][Full Text] [Related]
27. A fast-dissolving microneedle array loaded with chitosan nanoparticles to evoke systemic immune responses in mice.
Li Z; He Y; Deng L; Zhang ZR; Lin Y
J Mater Chem B; 2020 Jan; 8(2):216-225. PubMed ID: 31803892
[TBL] [Abstract][Full Text] [Related]
28. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
Tezel A; Paliwal S; Shen Z; Mitragotri S
Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
[TBL] [Abstract][Full Text] [Related]
29. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
[TBL] [Abstract][Full Text] [Related]
30. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.
Belyakov IM; Hammond SA; Ahlers JD; Glenn GM; Berzofsky JA
J Clin Invest; 2004 Apr; 113(7):998-1007. PubMed ID: 15057306
[TBL] [Abstract][Full Text] [Related]
31. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
32. A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization.
Wu X; Li Y; Chen X; Zhou Z; Pang J; Luo X; Kong M
J Mater Chem B; 2019 Aug; 7(31):4854-4866. PubMed ID: 31389952
[TBL] [Abstract][Full Text] [Related]
33. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.
Ding Z; Verbaan FJ; Bivas-Benita M; Bungener L; Huckriede A; van den Berg DJ; Kersten G; Bouwstra JA
J Control Release; 2009 May; 136(1):71-8. PubMed ID: 19331846
[TBL] [Abstract][Full Text] [Related]
34. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.
Hammond SA; Guebre-Xabier M; Yu J; Glenn GM
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):503-26. PubMed ID: 11763499
[TBL] [Abstract][Full Text] [Related]
35. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
[TBL] [Abstract][Full Text] [Related]
36. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
[TBL] [Abstract][Full Text] [Related]
37. Transcutaneous immunization of recombinant Staphylococcal enterotoxin B protein using a dissolving microneedle provides potent protection against lethal enterotoxin challenge.
Liu S; Zhang S; Duan Y; Niu Y; Gu H; Zhao Z; Zhang S; Yang Y; Wang X; Gao Y; Yang P
Vaccine; 2019 Jun; 37(29):3810-3819. PubMed ID: 31147275
[TBL] [Abstract][Full Text] [Related]
38. Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization.
Rattanapak T; Birchall JC; Young K; Kubo A; Fujimori S; Ishii M; Hook S
PLoS One; 2014; 9(2):e89503. PubMed ID: 24586830
[TBL] [Abstract][Full Text] [Related]
39. Transcutaneous tumor vaccination combined with anti-programmed death-1 monoclonal antibody treatment produces a synergistic antitumor effect.
Song X; Jiang Y; Zhang W; Elfawal G; Wang K; Jiang D; Hong H; Wu J; He C; Mo X; Wang H
Acta Biomater; 2022 Mar; 140():247-260. PubMed ID: 34843953
[TBL] [Abstract][Full Text] [Related]
40. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
Widera G; Johnson J; Kim L; Libiran L; Nyam K; Daddona PE; Cormier M
Vaccine; 2006 Mar; 24(10):1653-64. PubMed ID: 16246466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
